Add Yahoo as a preferred source to see more of our stories on Google. NEW YORK (AP) -- Pfizer said Thursday it is recalling some lots of its antidepressant Effexor XR because a single capsule of a ...
Struggling with depression or anxiety can feel overwhelming—and deciding whether to start a medication like Effexor adds another layer of uncertainty. If you've been prescribed this antidepressant or ...
Philadelphia, PA, May 21, 2002 –Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced today that 67 percent of patients with depression maintained remission of their symptoms, a critical ...
Pfizer is voluntarily recalling some lots of its antidepressant Effexor XR because a single capsule of a different medication was found in one bottle of the drug.The recall is for one lot of 30-count ...
Madison, NJ, February 11, 2003 -- Wyeth (NYSE:WYE) announced today that the U.S. Food and Drug Administration (FDA) approved EFFEXOR (R) XR (venlafaxine HCl) for the treatment of patients with social ...
Is there any benefit to using venlafaxine extended-release, 75 mg twice daily, vs venlafaxine extended-release, 150 mg once daily? Would the drug level, once at steady state, be higher given the daily ...
(RTTNews) - Viatris (VTRS) reported positive top-line results of Phase 3 study in Japan evaluating the safety and efficacy of EFFEXOR in adults with generalized anxiety disorder. The study achieved ...
PHILADELPHIA (CN) - The Third Circuit breathed new life Monday into antitrust lawsuits against four pharmaceuticals giants concerning the delayed entry to the market of generic versions of Lipitor and ...
Q. I tried to get off Effexor XR (venlafaxine) a few years ago, and the results were typical: agony, muscle aches, “brain zaps” and a depression worse than I had before starting on the drug. Six ...
CVS Caremark and Rite Aid have signed on to the Effexor XR conspiracy theory. In an antitrust lawsuit, the drugstore chains allege that Pfizer's ($PFE) Wyeth unit and ...
Of course, the drugmakers have their own points of view about their Effexor XR patent settlement. "Pfizer categorically denies the claims asserted in the plaintiffs' complaints," spokesman Christopher ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results